TLDR A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.
A 39-year-old woman experienced sudden graying and diffuse hair loss, diagnosed as Marie Antoinette syndrome, following the Pfizer/BioNTech COVID-19 vaccine. The condition worsened after the second dose but improved significantly with oral prednisone and topical clobetasol treatment, showing almost complete hair regrowth and partial repigmentation after 6 weeks. This case, along with a review of 14 similar cases, suggests a potential link between mRNA COVID-19 vaccines and alopecia areata, particularly in females, with a need for further studies on long-term outcomes.
36 citations,
June 2009 in “Archives of Dermatology” Marie Antoinette syndrome causes sudden hair whitening, but its exact cause is unknown.
[object Object]
1 citations,
September 2022 in “Journal of The American Academy of Dermatology” Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.
1 citations,
January 2022 in “Dermatology Reports” Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.
2 citations,
September 2021 in “JAAD case reports” Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.
[object Object] 
6 citations,
January 2019 in “Indian Journal of Dermatology” About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.
36 citations,
May 2011 in “Dermatologic therapy” No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.
109 citations,
May 2011 in “Dermatologic Therapy” Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.
